Cambridge Investment Research Advisors, Inc. - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37
-43.9%
54,6000.0%0.00%
Q2 2023$66
+3.1%
54,6000.0%0.00%
Q1 2023$64
+48.8%
54,6000.0%0.00%
Q4 2022$43
-99.9%
54,6000.0%0.00%
Q3 2022$66,000
+32.0%
54,6000.0%0.00%
Q2 2022$50,000
-49.0%
54,600
-0.5%
0.00%
Q1 2022$98,000
+15.3%
54,8870.0%0.00%
Q4 2021$85,00054,8870.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Inspire Advisors, LLC 135,508$472,0000.15%
Wealth Advisory Solutions, LLC 156,850$546,0000.13%
Horst & Graben Wealth Management LLC 75,722$264,0000.07%
Miller Investment Management, LP 50,000$174,0000.03%
GSA CAPITAL PARTNERS LLP 44,655$155,0000.02%
Triton Wealth Management, PLLC 13,100$24,0000.01%
Renaissance Technologies 1,898,351$6,606,0000.01%
B. Riley Wealth Management, Inc. 19,000$66,0000.01%
Virtu Financial LLC 19,713$69,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 47,265$164,0000.01%
View complete list of CITIUS PHARMACEUTICALS INC shareholders